TOST — All updates

3 entries loaded; 0 direction changes

Filter loaded records
The CompoundPublished 2026-11-03
“The Death of AI Has Been Greatly Exaggerated | WAYT?”
$TOSTBullish
AI summary · The speaker remains long Toast and sees it as a great long-run opportunity. He cites a great report: GAAP EPS almost doubled year over year, ARR is about $10 billion, free cash flow keeps increasing, and earlier problems are fixed. Although shares fell $1.5 and after-hours moves are not meaningful, he sees market cap as very low versus the business; vertical SaaS is out of favor, but Toast dominates and is used in 189,000 locations.

Toast has published their report. This Actually a great report, so stock 1.5 The dollar has fallen, but since we are on the show, I've talked about it many times, so it's official.

For those who don't know, toast is fast. Payments for the hospitality industry and The most popular vertical software Becoming an important platform, just Not a restaurant, take-out business, retail The store and they just left the gas station. has also launched a vertical for.

This is not just a US business, it is International.

The Motley FoolPublished 2026-10-12
“3 Fintech Stocks That Could Be Much Bigger in 5 Years”
$TOSTBullish
AI summary · Toast, an integrated restaurant operating system, is gaining momentum: order value growth above 21% for several quarters, recurring revenue up 25% year over year, and 180,000 locations, up 21.6%. Its future looks bright as eating out rises, though restaurant concentration leaves it exposed if sector spending slows.

If you haven't looked at Toast recently, it's a restaurant operating system. Its use has increased significantly in the United States . Actually, I don't know if you know, but I opened a restaurant that uses Toast about ten years ago.

In 2017 we made our decisions, and we launched in 2018. I have a long history with this company, but its rating today is much better .

That's the earliest record
All updates for other tickers
Follow $TOST30-day free trial
Start trial